Abbott Laboratories (NYSE:ABT) Misses Q4 CY2025 Revenue Estimates, Stock Drops [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Its non-GAAP profit of $1.50 per share was in line with analysts' consensus estimates. Is now the time to buy Abbott Laboratories? Find out in our full research report Revenue: $11.46 billion vs analyst estimates of $11.8 billion (4.4% year-on-year growth, 2.9% miss) Adjusted EPS: $1.50 vs analyst estimates of $1.49 (in line) Adjusted EPS guidance for the upcoming financial year 2026 is $5.68 at the midpoint, in line with analyst estimates Operating Margin: 19.6%, up from 17.4% in the same quarter last year Organic Revenue rose 3% year on year (miss) Market Capitalization: $209.9 billion "In 2025, we expanded margins and achieved double-digit earnings per share growth, our new product pipeline was highly productive, and we took important strategic steps to shape the company for the future," said Robert B. Ford, chairman and chief executive officer, Abbott. With roots dating back to 1888 when founder Dr. Wallace Abbott began producing precise, dosage-form medications,
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- ABT Q4 Deep Dive: Nutrition Weakness and Innovation Shape 2026 Outlook [Yahoo! Finance]Yahoo! Finance
- Biosensors Market Forecast 2025-2033: Total Revenues to Exceed $75.84 Billion by 2033 | Astute Analytica [Yahoo! Finance]Yahoo! Finance
- Abbott Falls Most in Nearly 24 Years on Formula Pricing Stumble [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (ABT) Q4 2025 Earnings Call Highlights: Navigating Market Challenges with ... [Yahoo! Finance]Yahoo! Finance
- Why Abbott Laboratories (ABT) Shares Are Sliding Today [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 1/22/26 - In-Line
ABT
Sec Filings
- 1/22/26 - Form 8-K
- 1/5/26 - Form 4
- 1/5/26 - Form 4
- ABT's page on the SEC website